Gene expression profiling of colorectal adenomas and early invasive carcinomas by cDNA array analysis

[1]  H. Nielsen,et al.  Localization of tissue inhibitor of metalloproteinases 1 (TIMP‐1) in human colorectal adenoma and adenocarcinoma , 2005, International journal of cancer.

[2]  T. Roberts,et al.  The serine/threonine kinase cyclin G-associated kinase regulates epidermal growth factor receptor signaling. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[3]  J. Phang,et al.  Polyoma Enhancer Activator 3, an Ets Transcription Factor, Mediates the Induction of Cyclooxygenase-2 by Nitric Oxide in Colorectal Cancer Cells* , 2004, Journal of Biological Chemistry.

[4]  Arnulf H Hölscher,et al.  Loss of Smad4 correlates with loss of the invasion suppressor E‐cadherin in advanced colorectal carcinomas , 2004, The Journal of pathology.

[5]  F. Bertucci,et al.  Gene expression profiling of colon cancer by DNA microarrays and correlation with histoclinical parameters , 2004, Oncogene.

[6]  Nobuyoshi Shimizu,et al.  nm23‐H1 reduces in vitro cell migration and the liver metastatic potential of colon cancer cells by regulating myosin light chain phosphorylation , 2004, International journal of cancer.

[7]  Hiroyuki Yamamoto,et al.  Association of ets‐related transcriptional factor E1AF expression with tumour progression and overexpression of MMP‐1 and matrilysin in human colorectal cancer , 2003, The Journal of pathology.

[8]  C. Langner,et al.  IGF-1R, IGF-1 and IGF-2 expression as potential prognostic and predictive markers in colorectal-cancer , 2003, Virchows Archiv.

[9]  Mei-hua Xu,et al.  Role of inducible nitric oxide synthase expression in aberrant crypt foci-adenoma-carcinoma sequence. , 2003, World journal of gastroenterology.

[10]  T. Ørntoft,et al.  Classification of Dukes' B and C colorectal cancers using expression arrays , 2003, Journal of Cancer Research and Clinical Oncology.

[11]  Ugur Sahin,et al.  Computational dissection of tissue contamination for identification of colon cancer‐specific expression profiles , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[12]  R. Gaynor,et al.  Identification and Validation of Genes Involved in the Pathogenesis of Colorectal Cancer Using cDNA Microarrays and RNA Interference 1 , 2003 .

[13]  S. Ishii,et al.  Identification of expressed genes linked to malignancy of human colorectal carcinoma by parametric clustering of quantitative expression data , 2003, Genome Biology.

[14]  G. Berx,et al.  Smad4 induces the tumor suppressor E-cadherin and P-cadherin in colon carcinoma cells , 2002, Oncogene.

[15]  B. Leggett,et al.  Emerging concepts in colorectal neoplasia. , 2002, Gastroenterology.

[16]  T. Ørntoft,et al.  Gene expression in colorectal cancer. , 2002, Cancer research.

[17]  F. Sato,et al.  Application of cDNA microarrays to generate a molecular taxonomy capable of distinguishing between colon cancer and normal colon , 2002, Oncogene.

[18]  J. Coxhead,et al.  Mutations in APC, Kirsten-ras, and p53—alternative genetic pathways to colorectal cancer , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[19]  Yusuke Nakamura,et al.  Molecular diagnosis of colorectal tumors by expression profiles of 50 genes expressed differentially in adenomas and carcinomas , 2002, Oncogene.

[20]  Baljit Singh,et al.  Oncogenic β-Catenin Is Required for Bone Morphogenetic Protein 4 Expression in Human Cancer Cells , 2002 .

[21]  Alan Cantor,et al.  Osteopontin identified as lead marker of colon cancer progression, using pooled sample expression profiling. , 2002, Journal of the National Cancer Institute.

[22]  V. Sharov,et al.  Identification of tumor markers in models of human colorectal cancer using a 19,200-element complementary DNA microarray. , 2001, Cancer research.

[23]  M. Monden,et al.  Construction of preferential cDNA microarray specialized for human colorectal carcinoma: molecular sketch of colorectal cancer. , 2001, Biochemical and biophysical research communications.

[24]  T. Takagi,et al.  Alterations of gene expression during colorectal carcinogenesis revealed by cDNA microarrays after laser-capture microdissection of tumor tissues and normal epithelia. , 2001, Cancer research.

[25]  U. Alon,et al.  Transcriptional gene expression profiles of colorectal adenoma, adenocarcinoma, and normal tissue examined by oligonucleotide arrays. , 2001, Cancer research.

[26]  C. Boland,et al.  Genetic pathways in the evolution of morphologically distinct colorectal neoplasms. , 2001, Cancer research.

[27]  R. Minami,et al.  Flat-elevated and depressed, subtypes of flat early colorectal cancers, should be distinguished by their pathological features , 2000, International Journal of Colorectal Disease.

[28]  U. Mansmann,et al.  Differential gene expression in colon carcinoma cells and tissues detected with a cDNA array , 1999, International journal of cancer.

[29]  U. Alon,et al.  Broad patterns of gene expression revealed by clustering analysis of tumor and normal colon tissues probed by oligonucleotide arrays. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[30]  H. Höfler,et al.  Loss of heterozygosity and microsatellite instability in de novo versus ex-adenoma carcinomas of the colorectum. , 1998, The American journal of pathology.

[31]  G. Thomas,et al.  Somatically acquired genetic alterations in flat colorectal neoplasias. Int. J. Cancer 77, 366–369 (1998). , 1998, International journal of cancer.

[32]  M. Imamura,et al.  Expression of Insulin-Like Growth Factor-2 Can Predict the Prognosis of Human Colorectal Cancer Patients: Correlation with Tumor Progression, Proliferative Activity and Survival , 1998, Oncology.

[33]  K. Kohno,et al.  Enhanced expression of tissue inhibitors of metalloproteinases in human colorectal tumors. , 1996, Japanese journal of clinical oncology.

[34]  P Rhodes,et al.  Roles of nitric oxide in tumor growth. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[35]  J. Boniver,et al.  Abnormal expression and structural modification of the insulin‐like growth‐factor‐ii gene in human colorectal tumors , 1990, International journal of cancer.

[36]  S. Kuramoto,et al.  Flat early cancers of the large intestine , 1989, Cancer.

[37]  Y. Nakamura,et al.  Genetic alterations during colorectal-tumor development. , 1988, The New England journal of medicine.

[38]  J E Talmadge,et al.  Evidence for a novel gene associated with low tumor metastatic potential. , 1988, Journal of the National Cancer Institute.

[39]  Baljit Singh,et al.  Oncogenic beta-catenin is required for bone morphogenetic protein 4 expression in human cancer cells. , 2002, Cancer research.

[40]  H. Nielsen,et al.  Total levels of tissue inhibitor of metalloproteinases 1 in plasma yield high diagnostic sensitivity and specificity in patients with colon cancer. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[41]  M. Imamura,et al.  Possible paracrine mechanism of insulin‐like growth factor‐2 in the development of liver metastases from colorectal carcinoma , 1999, Cancer.